David J. Hunter

Perspective: Mesenchymal stromal cells and PRP in osteoarthritis: Hope, hype and the hard evidence.

In the absence of approved disease-modifying therapies for osteoarthritis (OA), regenerative therapies have emerged as promising interventions that have attracted considerable enthusiasm among patients, clinicians, and researchers. This interest has been particularly prominent in knee OA, where intra-articular orthobio...

Cross-Sectional and Longitudinal Association Between Biological Aging Acceleration and the Risk of Osteoarthritis: A Cohort Study From UK Biobank.